Abstract:Introduction: Head and neck cancer treatment optimization and individualization has become possible due to the implementation of the prognostic and predictive molecular markers in diagnostics. Aim: The aim of this study was an attempt to determine which of the investigated molecular markers may have prognostic and predictive value in head and neck cancers. Materials and methods: The paraffin blocks from 47 patients with oral and lip squamous cell carcinoma (SCC) after surgical treatment in the Institute of Oncology in Gliwice in the period of 1998-2002 were investigated. For immunohistochemical studies the DAKO monoclonal antibodies were used: p53, Ki67, Cyclin D1, Cathepsin B and Cox2-Cayman Chemical antibody. Staining reactions were evaluated at 400x magnification. The average percent of staining cells was estimated in every case in the groups of patients with (N+) and without (No) node metastases. The results were subsequently juxtaposed with selected clinical and histological parameters. Statistical analysis was performed with Mann-Whitney and Kruskal-Wallis tests and the log rank test with a significance level of 0.05 (p = 0,05). Results: Significantly higher expression of Ki67 in N+ patients (p = 0,010) were recorded, although average staining in the group of treated and the group of unhealed patients was statistically insignificant. Cathepsin B expression (<20% and > 20%) was correlated with 3 year-long survival and a slight higher average staining (33,5%) in unhealed in comparison with treated patients (29,0%) was notified. Everage expression of p53 in unhealed patients (33,1%) was slightly higher than in treated ones (28,4%). Weaker Cyclin D1 expression (<10%) correlated with higher disease free survival. Average Cycline D1 staining in the groups of unhealed patients (19,6%) was higher than in the treated ones (12,0%). There were no significant differences in COX-2 staining in correlation with clinical and histological parameters. Conclusions: Lower expression of Cyclin D1 and Cathepsin B in neoplastic cells correlated with higher percentage of disease free survival what suggests the prognostic value of these markers. Higher proliferation activity of primary tumor neoplastic cells correlated with node metastases what may has the predictive value in the course of the disease.The different markers expressions observed in the different oral cavity localizations confirm the necessity to select patients for further investigations with respect to uniform disease changes topography.

Cellular profile of the peritumoral inflammatory infiltrate in squamous cells carcinoma of oral mucosa: Correlation with the expression of Ki67 and histologic grading

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

Evaluation of tumor-infiltrating T & B lymphocytes and their association and distribution in oral squamous cell carcinoma tumor microenvironment: An in vitro immunohistochemical study

Expression of Ki67 as potential biomarker in oral submucous fibrosis: An immunohistochemical study

Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma

Prognostic Potential of Tumor-Infiltrating Immune Cells in Resectable Oral Squamous Cell Carcinoma

The expression of P27kipl and Ki-67 in squamous cell carcinoma of mouthfloor and its significance

An Immunohistochemical Study on Ki-67 Expression in Squamous Cell Carcinomas of Cervix With Clinicopathological Correlation

Biomarker Profiles and Clinicopathological Features in Head and Neck Squamous Cell Carcinoma Patients

Ki67 Proliferation Index As a Histopathological Predictive and Prognostic Parameter of Oral Mucosal Melanoma in Patients Without Distant Metastases.

What is the Prognostic Significance of Ki-67 Positivity in Oral Squamous Cell Carcinoma?

Expression of P16, P53 and Ki-67 Proteins in the Progression of Epithelial Dysplasia of the Oral Cavity.

Immunohistochemical Analysis of Dendritic Cell in Oral Squamous Cell Carcinoma

Higher Ki67 expression in fibroblast like cells at invasive front indicates better clinical outcomes in oral squamous cell carcinoma patients.

PD-L1 expression in tumor tissue and peripheral blood of patients with oral squamous cell carcinoma

Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma.

[Prognostic molecular markers in oral and lip squamous cell carcinoma--evaluation of expression and its significance]

Differential infiltration of neutrophils in T1–T2 versus T3–T4 oral squamous cell carcinomas: a preliminary study

Histological pattern of tumor inflammation and stromal density correlate with patient demographics and immuno-oncologic transcriptional profile in oral squamous cell carcinoma

Evaluation of HPV and EBV in OSCC and the expression of p53, p16, E-cadherin, COX-2, MYC, and MLH1

Expression of Fascin and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance